Caring Connections: A Program to Alleviate Social Isolation and Loneliness in Individuals Living With Spinal Cord Injury
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05295108 |
Recruitment Status :
Not yet recruiting
First Posted : March 24, 2022
Last Update Posted : February 8, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Spinal Cord Injuries and Disorders (SCI/D) | Other: Caring Connections Other: Attention control | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 62 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Randomized controlled trial comparing intervention with attention control condition. |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Caring Connections: A Program to Alleviate Social Isolation and Loneliness in Individuals Living With Spinal Cord Injury |
Estimated Study Start Date : | November 2023 |
Estimated Primary Completion Date : | January 2024 |
Estimated Study Completion Date : | April 29, 2025 |

Arm | Intervention/treatment |
---|---|
Experimental: Caring Connections intervention
The Caring Connections intervention will consist of non-demanding, messages of care and concern delivered to individuals with SCI/D who had moderate to high social isolation and/or loneliness scores on the baseline survey. The caring messages will be in the form of structured, yet personalized mailed letters from one consistent peer with SCI/D, providing long-term and steady contact. Intervention participants will receive a letter every month over a 6-month period. Following a standardized set of principles, letters will contain cheerful expressions of care and micro-moments of positivity. The PI/Co-Is will provide a brief training and work with volunteer peers with SCI/D to write the letters.
|
Other: Caring Connections
peer-based letter writing social connectedness intervention to improve social health outcomes |
Active Comparator: Attention control
We will mail informational materials to individuals with SCI/D in our control group at the same timepoints over 6 months as our intervention letter mailings. The informational materials will discuss life domains that are important to a good quality of life. Topics include community living, physical/healthy living, safety and security, social/spirituality, advocacy/engagement, and employment/volunteering. We will draw information for each topic from the Knowledge Translation Center SCI Factsheets (MSKTC 2021) and the LifeCourse Nexus library (2021).
|
Other: Attention control
informational materials provided to educate on life domains that are important to social health |
- loneliness [ Time Frame: change from baseline to post-RCT (6 months) ]UCLA 3-item Loneliness Scale
- social isolation [ Time Frame: change from baseline to post-RCT (6 months) ]PROMIS Social Isolation 8-item
- social contact with friends/family [ Time Frame: change from baseline to post-RCT (6 months) ]frequency: Once a week, Several times a week, About once a month, Several times a year, About once or twice a year, Less than once a year, Never)
- social contact with organized groups (Examples include: a choir, a committee or board, a support group, a sports or exercise group, a hobby group, or a professional society.) [ Time Frame: change from baseline to post-RCT (6 months) ]frequency: Once a week, Several times a week, About once a month, Several times a year, About once or twice a year, Less than once a year, Never)
- perceived benefit from the intervention [ Time Frame: post-RCT at 6 months ]5-point Likert scale (No benefit, Minor benefit, Neutral, Moderate benefit, Major benefit)
- perceived negative impacts from the intervention [ Time Frame: post-RCT at 6 months ]5-point Likert scale (No negative impacts, Minor negative impacts, Neutral, Moderate negative impacts, Major negative impacts)
- satisfaction with the intervention [ Time Frame: post-RCT at 6 months ]5-point Likert scale (Very Satisfied, Satisfied, Neutral, Dissatisfied, Very Dissatisfied)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Our target population will include adult Veterans with chronic SCI/D (duration of injury > 1 year); this may include those with traumatic and non-traumatic SCI/D, and may include SCI, nonmalignant neoplasms resulting in neurologic deficit; vascular insults of a thromboembolic, hemorrhagic, or ischemic nature; cauda equina syndrome producing neurologic deficit; inflammatory disease of the spine, spinal cord, or cauda equina resulting in non-progressive neurologic deficit; and demyelinating disease of the spinal cord.
Exclusion Criteria:
- Veterans with SCI/D under the age of 18 will be excluded. Individuals with new injuries (injury duration less than one year) will be excluded as it is plausible that social isolation and loneliness may more likely occur after the first year of injury when individuals have transitioned to the community and may no longer be surrounded by people consistently for help with their acute care needs (Dickson 2011). There are no SCI/D level or severity exclusions, as we wish to reach a diverse group of individuals.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05295108
Contact: Sherri LaVela, PhD, MPH, MBA | 708-202-5895 | sherri.lavela@va.gov |
Principal Investigator: | Sherri LaVela, PhD, MPH, MBA | Department of Veterans Affairs, Hines VA |
Responsible Party: | Sherri LaVela, Research Health Scientist, Chicago Association for Research and Education in Science |
ClinicalTrials.gov Identifier: | NCT05295108 |
Other Study ID Numbers: |
864046 |
First Posted: | March 24, 2022 Key Record Dates |
Last Update Posted: | February 8, 2023 |
Last Verified: | February 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Spinal Cord Injuries Wounds and Injuries Spinal Cord Diseases |
Central Nervous System Diseases Nervous System Diseases Trauma, Nervous System |